The Bioequivalence of Tafamidis 61‐mg Free Acid Capsules and Tafamidis Meglumine 4 × 20‐mg Capsules in Healthy Volunteers

Tafamidis, a non‐nonsteroidal anti‐inflammatory benzoxazole derivative, acts as a transthyretin (TTR) stabilizer to slow progression of TTR amyloidosis (ATTR). Tafamidis meglumine, available as 20‐mg capsules, is approved in more than 40 countries worldwide for the treatment of adults with early‐sta...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Pharmacol Drug Dev
Main Authors: Lockwood, Peter A., Le, Vu H., O'Gorman, Melissa T., Patterson, Terrell A., Sultan, Marla B., Tankisheva, Ekaterina, Wang, Qiang, Riley, Steve
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2020
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7754314/
https://ncbi.nlm.nih.gov/pubmed/32196976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.789
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki